ELTP
Elite Pharmaceuticals, Inc.

3,268
Mkt Cap
$515.81M
Volume
352,292.00
52W High
$0.8194
52W Low
$0.27
PE Ratio
85.71
ELTP Fundamentals
Price
$0.4771
Prev Close
$0.48
Open
$0.4799
50D MA
$0.5357
Beta
0.45
Avg. Volume
612,411.77
EPS (Annual)
-$0.004
P/B
8.37
Rev/Employee
$1.24M
News
all
press releases
ELTP Stock Declines Despite Solid Q2 Earnings and Revenue Performance
Elite Pharmaceuticals delivers record second-quarter fiscal 2026 earnings as lisdexamfetamine sales surged, though margins faced competitive pressure.
Zacks·2mo ago
News Placeholder
More News
News Placeholder
The Zacks Analyst Blog Highlights Berkshire Hathaway, Toyota Motor, McDonald's, Elite Pharmaceuticals and BK Technologies
Zacks highlights Berkshire Hathaway, Toyota, McDonald's, Elite Pharma and BK Technologies as diverse plays with unique growth catalysts and risks.
Zacks·5mo ago
News Placeholder
Top Analyst Reports for Berkshire Hathaway, Toyota Motor & McDonald's
Analysts spotlight Berkshire, Toyota and McDonald's, highlighting growth drivers, risks and market performance in new research reports.
Zacks·5mo ago
News Placeholder
ELTP Stock Gains Following Q1 Earnings Showing Strong Revenue Growth
Elite Pharmaceuticals reports strong first-quarter fiscal 2026 results with rising direct sales, higher-margin products and expanding gross profit.
Zacks·5mo ago
News Placeholder
2 Outperform Rated Small Caps with Recent Pull-backs
ELTP and TSSI are growth stories with recent material pull-backs.
Zacks·5mo ago
News Placeholder
The Zacks Analyst Blog Highlights Cisco Systems, Caterpillar, Charles Schwab and Elite Pharmaceuticals
CSCO, CAT, SCHW and ELTP are driving gains with strong segment growth, strategic deals, and rising investor interest in key sectors.
Zacks·6mo ago
News Placeholder
Top Analyst Reports for Cisco, Caterpillar & Charles Schwab
CSCO, CAT and SCHW shares outperformed peers as analysts highlight growth drivers and risks in key business segments.
Zacks·6mo ago
News Placeholder
Elite Pharmaceuticals Stock Dips Despite Record FY25 Revenue Jump
ELTP posts record fiscal 2025 revenues and operating income gains, fueled by new launches and expanding generics market share.
Zacks·7mo ago
<
...
1
>

Latest ELTP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.